Rebuilding the Missing Part—A Review on Photoreceptor Transplantation by Tiago F. Santos-Ferreira et al.
REVIEW
published: 05 January 2017
doi: 10.3389/fnsys.2016.00105
Frontiers in Systems Neuroscience | www.frontiersin.org 1 January 2017 | Volume 10 | Article 105
Edited by:
Volker Busskamp,
DFG-Center for Regenerative
Therapies Dresden, Germany
Reviewed by:
Karl Farrow,
Neuroelectronics Research Flanders,
Belgium
Rachael Pearson,
University College London (UCL), UK
Sandra Siegert,
Institute of Science and Technology
Austria, Austria
*Correspondence:
Marius Ader
marius.ader@crt-dresden.de
Received: 30 September 2016
Accepted: 12 December 2016
Published: 05 January 2017
Citation:
Santos-Ferreira TF, Borsch O and
Ader M (2017) Rebuilding the Missing
Part—A Review on Photoreceptor
Transplantation.
Front. Syst. Neurosci. 10:105.
doi: 10.3389/fnsys.2016.00105
Rebuilding the Missing Part—A
Review on Photoreceptor
Transplantation
Tiago F. Santos-Ferreira, Oliver Borsch and Marius Ader *
DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence, Technische Universität Dresden, Dresden, Germany
Vision represents one of the main senses for humans to interact with their environment.
Our sight relies on the presence of fully functional light sensitive cells – rod and
cone photoreceptors — allowing us to see under dim (rods) and bright (cones) light
conditions. Photoreceptor degeneration is one of the major causes for vision impairment
in industrialized countries and it is highly predominant in the population above the
age of 50. Thus, with the continuous increase in life expectancy it will make retinal
degeneration reach an epidemic proportion. To date, there is no cure established for
photoreceptor loss, but several therapeutic approaches, spanning from neuroprotection,
pharmacological drugs, gene therapy, retinal prosthesis, and cell (RPE or photoreceptor)
transplantation, have been developed over the last decade with some already introduced
in clinical trials. In this review, we focus on current developments in photoreceptor
transplantation strategies, its major breakthroughs, current limitations and the next
challenges to translate such cell-based approaches toward clinical application.
Keywords: retina, photoreceptor, retinal degeneration, transplantation, embryonic stem cell, induced pluripotent
stem cell, pre-clinical mouse models, cytoplasmic exchange
INTRODUCTION
The ability to visually perceive the surrounding world is provided by an elegantly designed organ—
the eye—which contains light sensing cells: rod and cone photoreceptors. Several diseases, such as
retinitis pigmentosa (RP, Hartong et al., 2006), Leber’s Congenital Amaurosis (LCA, den Hollander
et al., 2008) and age-related macular degeneration (AMD, Jager et al., 2008) result in the functional
impairment and loss of photoreceptors leading to vision impairment and ultimately blindness.
Blindness alone affects 34 million people worldwide and, with an ever-increasing population and
its continuous aging, blinding diseases may reach epidemic levels (WHO, 2016, Visual impairment
and blindness). The perspective of an even “darker” future has led to the development of multiple
therapeutic approaches including neuroprotection (Trifunovic´ et al., 2012), gene therapy (Acland
et al., 2001), antibody therapy (Lazic andGabric, 2007), optogenetics (Busskamp et al., 2010), retinal
prosthesis (Lewis et al., 2016), and cell replacement therapy.
Whereas, some of these treatment approaches aim to rescue remaining photoreceptors and thus
have to be applied at early stages of the disease (e.g., gene therapy, neuroprotection, pharmacology),
other therapeutic interventions target late disease stages, when the majority or all photoreceptors
have been lost, making them particularly challenging (Figure 1). Interestingly, the neurons of
the inner nuclear layer (INL), i.e., horizontals, bipolars, and amacrines, survive for extended
time periods after photoreceptor degeneration despite significant dendritic retraction and circuit
remodeling. Therefore, one strategy is to prevent degeneration of second-order neurons combined
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FIGURE 1 | Photoreceptor degeneration and potential therapies. Schematic overview of several therapeutic approaches and their application based on the
disease progression and amount of photoreceptors left. Initial therapeutic approaches such as neuroprotection, gene therapy, and antibody therapy require the
presence of endogenous photoreceptors to be effective. Conversely, optogenetics, retinal prosthesis, photoreceptor replacement therapies, and photo-switchable
compounds aim to treat patients in the late stages of the disease where few or no photoreceptors are left. Optogenetic approaches can also be used to reactivate
remaining but dysfunctional cone photoreceptors.
with the restoration of photoreceptor-mediated light sensitivity
in order to take advantage of the processing within the natural
retinal circuitry (Jones et al., 2016; Reh, 2016). To bypass the
loss of sensory input, optogenetic tools, or photoswitchable
compounds (Tochitsky et al., 2016) have been explored, which
either make bipolar or ganglion cells light-sensitive or even re-
activate remaining cone photoreceptors (Busskamp et al., 2010)
in diseases such as retinitis pigmentosa. Moreover, recently the
grafting of artificial light sensing devices, i.e., retinal prostheses,
that provide INL neurons with electrical stimuli, received FDA
approval and have restored some basic visual function to affected
patients in first clinical applications (da Cruz et al., 2016).
Thus, diseases characterized by photoreceptor loss might
be also amenable to cell replacement therapies based on the
following reasons: first, the eye is a separated organ that
can be relatively easily accessed and manipulated. Second,
photoreceptors are located adjacent to an epithelial layer—the
retinal-pigmented epithelium (RPE). The contact between RPE
and the outer segments (OSs) of photoreceptors is relative loose
and creates a natural cleft that can be separated upon injection
of a solution containing donor cells. Third, the eye represents a
partially immune-privileged organ that is less prone to immune
rejection of foreign material (Streilein et al., 2002; Forrester,
2008), and fourth, transplanted photoreceptors have to extend
their axons just a few micrometers in order to establish synaptic
connections to horizontal and bipolar cells.
In this review, we will provide an overview of photoreceptor
transplantation studies and in which directions the field is
currently moving. Additionally, we will refer and discuss a
critical concept: structural integration of donor cells into the
host retinal tissue. Until very recently donor photoreceptors
were understood to physically migrate and integrate into the
recipient outer nuclear layer (ONL) as identified by fluorescent
donor proteins being present within the host tissue. However,
three recent studies provided evidence that structural integration
represents a minor mechanism for this observation and that
exchange of cell material between donor and host photoreceptors
account for the majority of reporter labeled cells seen in the
host retina (Pearson et al., 2016; Santos-Ferreira et al., 2016a;
Singh et al., 2016). These novel results are discussed in detail
in section “Paradigm Shift in Photoreceptor Replacement
Therapy”, but for simplicity purposes and taking in account the
historical context, we will describe all reporter labeled cells found
within the host retina of previous studies as “integrated”
or refer generally to improved/reduced transplantation
outcomes.
DEVELOPMENT OF PHOTORECEPTOR
REPLACEMENT THERAPY
In the late 80s Del Cerro, Silvermann, Hughes, and Gouras
pioneered photoreceptor transplantation into the subretinal
space of rats or mice. Despite technical limitations at the time,
key ideas such as the need of tracing grafted cells (del Cerro
et al., 1989a,b; Gouras et al., 1991a,b,c; Du et al., 1992) or
enriching donor cells (by ONL vibratome sectioning or micro-
aggregates; Gouras et al., 1994) prior to transplantation, were
already explored. The potential of photoreceptor replacement
was evident in these initial studies that showed graft-survival up
to 9 months in wild-type hosts or in a mouse model of retina
degeneration, formation of primitive outer-segments (OS) and
synapses (del Cerro et al., 1989a; Gouras et al., 1991a,b,c, 1994;
Du et al., 1992).
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Several studies then aimed for the replacement of lost
photoreceptors using expanded retinal progenitor cells, primary
retinal- or photoreceptor sheets (Coles et al., 2004; Klassen et al.,
2004; Merhi-Soussi et al., 2006), however, full differentiation
of donor cells into mature photoreceptor phenotypes and
significant visual improvement was rarely observed arguing for
further improvement of such approaches (Ballios et al., 2015).
Particularly, the use of in vitro expanded retinal progenitor
cells (RPCs), also termed retinal stem cells, for photoreceptor
replacement (Klassen et al., 2004) has been recently challenged
by studies that suggested limited differentiation potential of
these cells toward the photoreceptor lineage (Cicero et al.,
2009; Gualdoni et al., 2010; Czekaj et al., 2012; Ringuette
et al., 2014). Nevertheless, recently the first clinical trial using
in vitro expanded human RPCs has been initiated (jCYTE;
www.clinicaltrials.gov; ID: NCT02320812).
YOUNG POST-MITOTIC
PHOTORECEPTORS SHOW IMPROVED
TRANSPLANTATION OUTCOME
A major breakthrough in photoreceptor transplantation was
achieved by MacLaren et al. (2006) followed by Bartsch et al.
(2008) wherein the optimal age of donor photoreceptors for
transplantation was identified resulting in higher survival and
integration rates. Young post-mitotic rod photoreceptors from
eGFP expressing reporter mouse lines isolated using fluorescent
activated cell sorting (FACS) at the peak of rod genesis, i.e., at
postnatal day (P) 4–6, were shown to integrate more efficiently
into wild-type and degenerating retinas than retinal cells isolated
at earlier or later ontogenetic stages [i.e., from embryonic
day (E) 11.5 to adult]. Following grafting, GFP+ cells had
their cell bodies properly located within the host ONL and
formed synaptic terminals and outer segments resembling a
mature rod photoreceptor phenotype (MacLaren et al., 2006;
Bartsch et al., 2008). Integrated donor cells generated the
distinct photoreceptor synaptic triad connecting to horizontal
and bipolar dendrites (Pearson et al., 2012) and formed
outer segments with well-aligned, stacked disks visualized by
correlative light and electron microscopy (CLEM; Eberle et al.,
2012). Additionally, OS-like structures were also observed when
primary rods were grafted into a late-stage retinal degeneration
mouse model of autosomal dominant RP (P347S mouse; Li
et al., 1996) with a virtually complete loss of photoreceptors.
Interestingly, the cells remained in the subretinal space in clusters
but still generated OSwith similar morphological features (Eberle
et al., 2012).
Gust and Reh (2011) reported that adult photoreceptors were
still integration-competent, however, with significantly reduced
integration potential in adult wild-type recipients. Interestingly,
they also showed a strongly reduced survival potential of mature
photoreceptors compared to immature ones in vitrowhich might
be one factor for their low integration rates. The low survival rate
in turn might be a cell dissociation effect since protocols based
on enzymatic and mechanical dissociation lead to a major loss
of outer segments and axonal terminals resulting in accelerated
cell death (Zayas-Santiago and Derwent, 2009; Gust and Reh,
2011). It also remains to be shown whether transplanted adult
rods are able to integrate into mouse models of photoreceptor
degeneration.
Interestingly, survival of donor photoreceptors can be
improved using anti-apoptotic factors such as X-linked
inhibitor of apoptosis protein (XIAP). Treatment of P4
donor photoreceptors using adeno-associated virus (AAV)
vectors expressing XIAP significantly improved survival of
transplanted photoreceptors in long-term experiments (Yao
et al., 2011a). XIAP-treated grafts had a higher survival rate of
integrated rods up to 8 months in rd9 mice, a X-linked retinal
degeneration model. Despite their improved survival, alleged
integration rates varied depending on the host’s age: elderly
hosts were more permissive for potential cell integration when
compared to younger counterparts, reflecting the influence
of the host environment on transplantation outcome (Yao
et al., 2011a). These results contradict previous findings using
grafted neural progenitors into the mouse eye where younger
hosts provided better support than older hosts for a successful
transplantation outcome (Sakaguchi et al., 2003). Indeed,
distinct host environments as it is also observed in diverse
retinal degeneration models have been shown to have significant
influence on photoreceptor transplantation success (Barber
et al., 2013; see below). Nonetheless, improved donor survival
using XIAP treatment may represent an interesting tool for adult
donor photoreceptors to improve survival after transplantation.
DONOR PHOTORECEPTOR ENRICHMENT
Amajor limitation to achieve significant functional improvement
of photoreceptor-mediated vision might be the low number
of integrating donor cells. To increase the total number of
integrated cells two approaches were followed: first, manipulation
of the donor cells/transplantation technology and, second,
modification of the recipient retinas.
To increase the photoreceptor content in suspensions for
transplantation, donor cells were enriched from whole retina
extracts using either FACS or magnetic activated cell sorting
(MACS; Figure 2). Indeed, by using transgenic mice with
rod-specific expression of GFP, donor photoreceptors could be
efficiently enriched to >95% by flow cytometry that resulted
in significantly higher numbers of integrated photoreceptors
following transplantation (MacLaren et al., 2006; Lakowski et al.,
2011; Pearson et al., 2012; Barber et al., 2013; Warre-Cornish
et al., 2014). Alternatively, the use of cell surface markers was
exploited for photoreceptor enrichment, which presents a viable
alternative for clinical application by circumventing the need
for fluorescence reporter expression in donor cells, particularly
when applying MACS enrichment technology, as it is easier to
adapt to GMP conditions than flow cytometry. CD73 (ecto-5′-
nucleotidase) was identified as a marker for rod photoreceptors
(Koso et al., 2009; Eberle et al., 2011; Lakowski et al., 2011) and
was used either alone (Eberle et al., 2011) or in combination
with CD24 (Lakowski et al., 2011) for the enrichment of rod
photoreceptors prior transplantation resulting in significant
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FIGURE 2 | Overview of current approaches for photoreceptor generation, sorting and transplantation. Donor photoreceptors can be acquired from
multiple sources: primary rodent retinas, embryonic stem cells (ESCs) or reprogrammed somatic cells which give rise to induced pluripotent stem cells (iPSCs).
Expandable cell sources can be cultured using 3D technology resulting in the generation of photoreceptor rich retinal organoids. Donor cells can be enriched by
fluorescent activated cell sorting (FACS) or magnetic activated cell sorting (MACS) using fluorescent labels or cell surface markers (CD133+/CD73+/CD47+/CD24+,
or CD73+, respectively). Following transplantation into mouse models of retinal degeneration the potential for retinal repair is evaluated.
increase of integrated rods in the adult mouse retina. A similar
approach was undertaken using mouse embryonic stem cell-
(mESC) derived rods (see below), where a panel of antibodies was
identified (CD73+/CD133+/CD24+/CD47+/CD15−, named
photoreceptor precursor (PPr) panel) that exclusively label
transplantation competent rods. PPr-positive rods were able to
integrate to a higher extend when compared to eGFP labeled
rods enriched by FACS or donor cells enriched with a single
cell surface marker (Figure 2; Lakowski et al., 2015). Further,
additional cell surface markers have been identified such as
Cacna2d4, Kcnv2, and Cnga1 that potentially allow enrichment
of rod photoreceptors but the lack of reliable antibodies currently
limits their use (Postel et al., 2013; Kaewkhaw et al., 2015).
TRANS-VITREAL AND TRANS-SCLERAL
INJECTIONS
The delivering technique of donor photoreceptors might impact
graft efficiencies as well. Two routes are currently used for
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subretinal transplantation in rodents: trans-vitreal and trans-
scleral injections (Figure 3). Both techniques reveal high levels of
efficacy in delivering donor cells to the subretinal space but they
might induce different responses in the host eye. In a trans-vitreal
approach, the injection needle has to pierce through the retina,
which will induce some local retinal gliosis, while a trans-scleral
approach partially avoids such detrimental outcome. In addition,
trans-scleral injections allow the targeting of two injection sites
in one session of transplantation while such approach is difficult
to be performed by a trans-vitreal route. Unfortunately, in trans-
scleral injections the experimenter cannot clearly visualize the
blood vessel network adjacent to the retina (choroid), thus
increasing the risk of severe hemorrhage in case of damage.
Conversely, trans-vitreal injections are currently used in clinical
applications for cell- and gene-based therapies and thus more
closely reflect a potential future clinical situation.
IMMUNE RESPONSE FOLLOWING
PHOTORECEPTOR TRANSPLANTATION
Graft survival is essential for a successful cell replacement
therapy, however, some studies suggest that the total number of
integrated rods dramatically declines from 3 to 4 months after
transplantation (West et al., 2010; Yao et al., 2011a). Immune
responses are discussed as a potential factor that contributes
to the poor long-term survival. The infiltration of immune
relevant cells such as macrophages and T-cells into the subretinal
space, as well as migration of microglia to the graft, have been
observed and correlated with reduced numbers of integrated
cells in the host ONL (West et al., 2010). The study by West
and colleagues were performed using donor cells and recipients
with partially matched haplotypes besides injection of unsorted
retinal cells, that were not enriched for photoreceptors, raising
the question to what extend matching haplotypes and specific
cell types influence immune responses in the retina. Interestingly,
systemic immune suppression by cyclosporine A resulted in
improved transplantation outcome (West et al., 2010). Other
immunosuppressants such as prednilosone or indomethacin
have been used to reduce immune response following Müller
Glia transplantation into RCS rats and allowed higher integration
rates (Singhal et al., 2008).
However, the role of innate immune cells in context
with retinal transplantation and degenerative disorders is not
understood in a detailed manner. Recently, Neves et al.
(2016) found that following photoreceptor transplantation the
modulation of innate retinal immune cells via the mesencephalic
astrocyte-derived neurotrophic factor (MANF) promoted retinal
repair. However, the exact mechanisms that might affect the
transplanted photoreceptors are not fully known. In that regard,
several questions should be addressed: What is the origin and
dynamics of the immune cells present in the graft? Are they
resident or circulating cells? What is their contribution to graft
depletion? Do different retinal degenerative diseases also lead
to distinct activation patterns of immune responses? In this
context a recent study using RPE transplantation provided
evidence for the importance of HLA matching also in the retina:
FIGURE 3 | Subretinal transplantation via trans-scleral or trans-vitreal
injection. Donor photoreceptors (green) can be transplanted into the donor’s
subretinal space either by trans-scleral or trans-vitreal injection. Subretinal
injection leads to transient detachment of the host retina (green bulge).
transplantations of haplotype matched iPSC-derived RPE cells
into the subretinal space of monkeys lacked T-cell mediated
immune responses whereas in non-matched conditions rejection
processes were observed (Sugita et al., 2016). Nevertheless, it
is currently under investigation to what extend graft purity
and matching haplotypes contribute to immune responses and
photoreceptor transplantation success.
MANIPULATION OF THE HOST RETINA
Within the recipient retina three components were identified
that might represent a major barrier for donor photoreceptor
migration into the host tissue: (i) the outer limiting membrane
(OLM); (ii) reactive gliosis; and (iii) the extracellular matrix
(ECM).
The OLM is composed of tight junctions between rod inner
segments and Müller glia (MG) end feet and constitutes a natural
barrier between the ONL and the inter-photoreceptor matrix, i.e.,
the sub-retinal space. To compromise Müller glia cell integrity,
the OLMwas disrupted by: (1) siRNAs against components of the
OLM, i.e., Crb1and ZO-1; or (2) the glial toxin alpha-aminoadipic
acid (AAA). This resulted in a higher number of integrated donor
cells within the host tissue (Pearson et al., 2010; West et al., 2010;
Barber et al., 2013).
Upon a retinal insult, whether genetic, chemical or
mechanical, Müller glia (MG) react in a non-specific manner
called reactive gliosis, that is characterized by up-regulation
of specific markers, hypertrophy, and sometimes proliferation.
The function of gliosis has not been fully understood as it
might have both beneficial and detrimental effects. In the case
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of retinal degenerations, the loss of photoreceptors leads to a
rearrangement of the ONL and respective OLM. MG become
reactive which can be identified by the presence of glial acidic
fibrillary protein (GFAP) and other intermediate filaments like
vimentin. The degree of MG activation is highly variable and
disease specific (Hippert et al., 2015). Gliosis might increase
the physical barrier of the OLM and therefore hinder the
migration of transplanted photoreceptors into the host retina
and formation of synaptic contacts to the second order neurons.
Indeed, mouse models of retinal degeneration with strong
MG activation are less permissive for donor photoreceptor
integration than models with lower reactive gliosis (Barber
et al., 2013). Furthermore, transplantation of retinal progenitors
into the subretinal space of a mouse model lacking GFAP and
vimentin lead to higher levels of donor cell migration into the
retinal tissue (Kinouchi et al., 2003), suggesting that Müller glia
activation might impair donor cell integration. It is hypothesized
that the absence of GFAP leads to a loosening of the OLM’s tight
junctions and, thus, promoting cell integration. However, GFAP
is also present in astrocytes which were never addressed in this
context, as they reside histologically distant from the subretinal
space in the GCL. Moreover, MG hypertrophy, MG swelling, and
thickening of the OLM might hinder photoreceptor integration
as well. Collectively, current data suggests that reactive Müller
glia is detrimental for successful migration and integration
of donor cells into degenerated retinas. However, further in
depth studies investigating the underlying mechanism(s) will
be required to develop distinct manipulations to improve the
transplantation outcome.
Another target within the host tissue that might influence
transplantation success in the retina are components of the
ECM, since these might pose a barrier for transplanted
photoreceptors to integrate and establish synaptic connections
to downstream neurons. Hence, the digestion of the ECM
using matrix metalloproteases (MMP2) or bacterial enzymes
(such as chondroitinase ABC) might facilitate migration and
synaptogenesis (Suzuki et al., 2007; Yao et al., 2011b; Barber et al.,
2013).
Overall, though a number of studies have assessed in detail
the characteristics of donor cells for retinal transplantation, only
few reports have analyzed the host response upon photoreceptor
transplantation. Thus, a systematic approach for identifying
conditions within the host tissue that allow successful migration
and integration of donor photoreceptors will be highly important
for the development of cell-based retinal replacement therapies.
ROD PHOTORECEPTOR
TRANSPLANTATION INTO RETINAL
DEGENERATION MOUSE MODELS
The ultimate goal of photoreceptor transplantation is to
repair lost visual function. Due to the availability of a wide
range of transgenic and chemical degeneration and reporter
strains, mice represent the main experimental species in retinal
transplantation research. However, mice are nocturnal animals
and do not rely as much on vision as humans, thus, some
researchers estimate the normal sight of mice is on a level that
would allow for a human to be recognized as legally blind (Baker,
2013). Therefore, the development of sensitive and reliable
methods for the evaluation of vision improvement following cell
transplantation is of utmost importance.
Indeed, improved visual function following cell
transplantation using a standard test for retinal function,
the electroretinogram (ERG), has only achieved very limited
results. This might be explained by low numbers of functionally
connected donor photoreceptors within recipient retinas as
the ERG represents a bulk analysis method that summarizes
electrical potentials from the whole retina (Peachey and Ball,
2003).
However, Pearson and colleagues observed some functional
restoration of rod-mediated vision following rod transplantation
in a mouse model of stationary night blindness using several
other vision-based tests (Pearson et al., 2012). The guanine
nucleotide-binding protein G subunit alpha-1 knockout mouse
model (Gnat1−/−) shows impaired rod phototransduction and
thus night blindness. Rod photoreceptors degenerate slowly in
Gnat1−/− mice and the authors hypothesized that at the time of
transplantation the remaining endogenous photoreceptors might
provide a natural scaffold for donor photoreceptors to integrate.
Restoration of rod vision by photoreceptor transplantation was
validated at the cellular, retinal, visual cortex as well as behavioral
level using a number of methodologies including single cell
electrophysiology, optokinetic tracking, cortical imaging, and a
water maze behavioral test (Pearson et al., 2012; Barber et al.,
2013), providing strong evidence for the feasibility of such
therapeutic approach.
Actually, most transplantation studies used animal models
of retinal degeneration with some remaining endogenous
photoreceptors that might facilitate donor cell integration and
polarization. However, end-stage degeneration with complete
loss of photoreceptors might represent the first target for future
clinical trials (Figures 1, 4). Therefore, mouse models with severe
retinal degeneration might represent an important and more
realistic environment for assessing the potential of photoreceptor
replacement approaches.
Initial experiments were performed by transplanting
photoreceptors into mouse models of severe retinal degeneration
like the rd1 or P347S mouse lines (Eberle et al., 2012; Singh et al.,
2013). Both studies provided evidence for survival of donor rods
with no migration into the remaining retinal tissue. Instead,
donor rods formed cell clusters within the host sub-retinal
space in close contact to the recipient’s INL. Interestingly, donor
rods expressed phototransduction cascade as well as synaptic
markers and generated disc-filled outer segment-like structures
with light dependent translocation of rod transducin between
cell body and outer segments, suggesting the differentiation
of donor cells into mature photoreceptors (Peachey and Ball,
2003; Eberle et al., 2012). Furthermore, several vision-based
tests were used, including electroretinography, light/dark
box, pupillary reflex, and laser speckle cortical imaging, that
suggested functional repair upon cell replacement therapy
(Singh et al., 2013). Interestingly, the visual improvements
were observed following rod photoreceptor transplantation
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FIGURE 4 | Cellular changes during severe photoreceptor degeneration and subsequent photoreceptor transplantation. (A) Morphological changes of
different retinal cell types following complete degeneration of photoreceptors. During photoreceptor degeneration, Müller glia becomes reactive, resulting in a
thickening of the OLM accompanied by reduction of dendritic arborization of bipolar and horizontal cells. Interneurons become misplaced at later stages of
degeneration. RPE: retinal pigment epithelium; ONL: outer nuclear layer; INL: inner nuclear layer; RGL: retinal ganglion cell layer. (B) Primary or h/m ESC/iPSC-derived
photoreceptor cells transplanted into a retina with complete photoreceptor degeneration remain in the subretinal space. Nrl: neural leucine zippe; eGFP: enhanced
green fluorescent protein; h: human; m: mouse; ESC: embryonic stem cells; iPSC: induced pluripotent stem cells.
into the widely used rd1 retinal degeneration mouse model
which is characterized by a rapid and severe photoreceptor
loss. However, recent publications identified a second mutation
in rd1 mice on the Gpr179 gene that effects ON-bipolar cells
(Peachey et al., 2012; Balmer et al., 2013; Nishiguchi et al.,
2015), the prime target of rod signaling. Only after backcrossing
rd1/3H9 to a C57BL/6j background, thereby eliminating the
mutation, allowed functional repair by gene therapy, thus
explaining the failure of several earlier gene therapeutic attempts
to repair retinal function in this model despite rescue of rod
photoreceptors (Bennett et al., 1996). Recently, the function
of GPR179 protein was identified and showed to be required
for depolarizing ON-bipolar cells (Peachey et al., 2012). Thus,
further experiments are required to determine the feasibility of
cell replacement therapies in severely degenerated recipients like
the rd1 mouse.
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Another interesting question is, to what extent the
transplantation of a photoreceptor suspension into the sub-
retinal space of severely degenerated retinas allows the (self-)
organization/reconstruction of a highly polarized structure as
the ONL. The clusters formed by donor rods in the sub-retinal
space did not show an obvious polarization or organization
and frequently donor photoreceptors did not generate the
characteristic stretched morphology with OSs contacting
the RPE and synapses localized to the IPL (Eberle et al.,
2012). However, the OSs of donor rods in rd1 mice showed a
preferential orientation toward the RPE suggesting some degree
of polarization within the host tissue (Singh et al., 2013).
Furthermore, it has not been analysed whether endogenous
Müller glia processes contact or enwrap grafted photoreceptors
as it is observed in wild-type retinas. Thus, further studies have
to be conducted to assess polarization of transplanted donor
photoreceptors in detail as well as determining the behavior
of the surrounding host cells (Müller glia, RPE and second
order neurons) following engraftment (Figure 4). Additionally,
the use of scaffolds or grafting of photoreceptor sheets (Seiler and
Aramant, 2012; Assawachananont et al., 2014) might represent
alternative routes for the generation of proper organized
photoreceptor transplants.
TRANSPLANTATION OF CONE/CONE-LIKE
PHOTORECEPTORS
Rod photoreceptors are important for vision under dim
light conditions but human vision is mainly dependent on
cone photoreceptors that mediate daylight and color vision
besides visual acuity due to their concentration in the macula.
Conversely, the mouse retina is adapted to night vision and
cones correspond to only 3% of all photoreceptors. Thus, to
investigate cone photoreceptor replacement therapy as it will be
necessary for macular degenerative diseases (e.g., AMD) or late
stage retinitis pigmentosa (RP) has been challenging due to the
absence of reliable reporter lines and comprehensive donor cell
sources.
The first study addressing cone transplantation relied on the
use of a Crx-GFP reporter line where GFP expression is under the
control of a cone-rod homeobox (Crx) promoter, labeling both
cone and rod photoreceptors (Lakowski et al., 2010). Crx is a
transcription factor that is expressed in all photoreceptors after
retinal progenitors commit to the photoreceptor lineage. Crx-
GFP positive cells were isolated at different developmental stages
from E12.5 to P3, sorted by flow cytometry and transplanted
into wild-type mice and a mouse model of cone degeneration.
There was an increase in the number of integrated Crx-GFP+
photoreceptors, both rods and cones, from E12.5 to P3 but the
total number of Crx-GFP+ cells within the ONL positive for
RXR-gamma, a cone photoreceptor marker, was significantly
higher when donor cells were isolated at embryonic stages. The
isolation and enrichment of mixed photoreceptor populations,
i.e., FAC-sorted Crx-GFP positive photoreceptors, does not
dissect the competence of cones to integrate when transplanted as
a pure population, whether into a rod- or cone-rich environment
(Lakowski et al., 2010). Additionally, the total number of cones in
an adult mouse retina is∼1.8× 105 cells (Jeon et al., 1998) which
limits the possibility to study cone photoreceptor transplantation.
To circumvent this drawback, our lab took advantage of
the neural retina leucine zipper transcription factor knockout
(Nrl−/−) mouse (Mears et al., 2001) in which the absence of
this rod-determining transcription factor results in a rod-less
retina where rods are converted into cone-like cells expressing
only short wavelength (S-) opsin (Mears et al., 2001). Cone-
like photoreceptors closely resemble wild-type cones at the
morphological, histological, electrophysiological and molecular
level (Daniele et al., 2005; Nikonov et al., 2005). These Nrl−/−
mice were crossed with an ubiquitous reporter mouse line (actin-
GFP) in order to trace cone-like cells after transplantation into
a mouse model of cone degeneration—the cone photoreceptor
function loss 1 (CPFL1) mouse (Chang et al., 2002, 2009).
Here, cone-like photoreceptors integrated into the recipient
ONL and resembled mature photoreceptors as they formed
outer-segments and expressed photo-transduction and synaptic
markers. Functional analysis was performed by micro-electrode
arrays (MEA), that allow the simultaneous read out of hundreds
of retinal ganglion cells (RGCs). These measurements showed
spike train responses in RGCs under daylight conditions (Santos-
Ferreira et al., 2015). Importantly, sham or rod photoreceptor
injected CPFL1 hosts were unable to detect high-intensity light
stimuli. These results suggest on the one side functionality of
transplanted cone-like photoreceptors to detect daylight stimuli
and on the other side proper connection of donor cells to the
retinal circuitry of the recipient. Therefore, MEA measurements
represent a highly sensitive tool to assess functional integration
of photoreceptors following transplantation. However, MEA
measurements were only performed 4 weeks after grafting despite
long term survival (up to 6 months) of donor cells. Thus, it
will be important to assess whether the observed functional
restoration is maintained over such extended periods after
transplantation.
Although cone-like cells were used as an alternative to cone
photoreceptors, they are, in fact, not true cones. Therefore,
several reporter lines have been developed in order to label
cone photoreceptors (Fei and Hughes, 2001; Smiley et al.,
2016). Smiley et al. (2016) generated a reporter line wherein
GFP is under the control of the coiled-coil domain containing
136 (Ccdc136) promoter. Despite heterogeneous expression
of GFP throughout more than one cell population (cones
and rod bipolars), GFP-positive cones are solely labeled until
P14, allowing their enrichment using FACS. Transplantation of
E17.5 Ccdc136GFP/+ sorted cell fractions resulted in integrated
photoreceptors in C57BL/6j wild-type hosts but these cells lacked
the expression of cone-specific photo-transduction markers
(Smiley et al., 2016) in contrast to Santos-Ferreira et al. (2015)
who showed cone markers (cone arrestin, s-opsin) in reporter
labeled cells following cone-like photoreceptor transplantation
into CPFL1 hosts. Interestingly, in both studies the reporter
labeled cells within the host ONL frequently exhibited rod-
like morphologies, that might be explained by the exchange
of cell material between donor and host photoreceptors (see
below).
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TRANSPLANTATION OF DONOR
PHOTORECEPTORS DERIVED FROM
PLURIPOTENT STEM CELLS
Despite all major achievements in restoring rod- and cone-
mediated vision, it is clear that primary cells cannot be used
in a clinical application for photoreceptor replacement purposes
without generatingmultiple ethical and logistical concerns. Thus,
an expandable, renewable source of donor cells has been pursued
and pluripotent (induced or embryonic) stem cells (iPSC/ESC)
represent an excellent alternative to primary cells. Several
laboratories are focused on the development of differentiation
protocols from iPSC/ESCs to photoreceptor fate and, nowadays,
several protocols with varying efficiencies are available but the
detailed discussion of these are beyond the scope of this review.
We will focus on transplantation studies using human or mouse
iPSC/ESC-derived photoreceptors as donor cells.
The first attempt to transplant pluripotent stem cell-derived
photoreceptors was performed by Lamba et al. (2009) using
human embryonic stem cell (hESC)-derived photoreceptors
as donor cells. Here, hESC-derived photoreceptors were
labeled with a lentiviral construct expressing eGFP under the
human elongation factor 1a (hEF1a) promoter in order to
trace donor cells after transplantation. Human ESC-derived
photoreceptors were grafted in both the vitreal and subretinal
space of mice and showed high migratory potential reaching
all the nuclear layers of the retina. Importantly, donor GFP-
positive cells integrated into the host’s ONL and displayed
a mature photoreceptor morphology as well as positivity
for recoverin and synaptophysin. Besides such promising
histological data also indications for functional recovery in the
retinal degeneration Crx−/− mouse model was reported (Lamba
et al., 2009).
Also iPSC-derived photoreceptors were transplanted with
varying degree of success (Lamba et al., 2010; Tucker et al., 2011;
Homma et al., 2013; Figure 2). Using a genetically encoded
reporter mouse iPSC reporter line (actin dsRed), dsRed+
iPSC-derived photoreceptor precursors were negatively-sorted
for stage-specific embryonic antigen-1 (SSEA1) to eliminate
potential proliferating and thus tumorigenic stem cells and then
grafted into rhodopsin knock-out mice at the age of 21 days.
Following transplantation fluorescently labeled cells were present
in the host ONL, expressed mature photoreceptor markers
and recovered some visual function as ERG measurements
showed a 100µV improvement in the b-wave (Tucker
et al., 2011). Although this study provides proof-of-concept
for miPSC-derived photoreceptor transplantation, a more
systematic analysis would be required to dissect the potential of
iPSC-derived photoreceptor for visual repair, especially at the
functional level. Homma and colleagues addressed this issue
by generating a mouse iPSC cell line from the Nrl-GFP mouse
and transplanted iPSC-derived rods into the wild-type and
dystrophic retina. Calcium imaging was performed showing
that grafted photoreceptors had similar intracellular calcium
oscillations upon pharmacological stimulation as endogenous
rod photoreceptors (Homma et al., 2013).
The above initial studies used pluripotent stem cell-derived
photoreceptors differentiated with 2D culture systems. However,
culture methods were significantly improved with the ground
breaking studies of the Sasai laboratory who introduced a
3D culturing system which allows mouse and hESC to self-
organize and differentiate along the retinal lineage by forming
organoids. These retinal organoids continue to develop into
an optic cup and subsequently pseudo-stratified retinal tissue
(Eiraku et al., 2011; Nakano et al., 2012). Retinal organoid
technology has become a widely used method to generate
transplantable photoreceptors as demonstrated by several
studies (Gonzalez-Cordero et al., 2013; Assawachananont et al.,
2014; Decembrini et al., 2014; Santos-Ferreira et al., 2016b).
Transplantation of retinal organoid-derived photoreceptors
showed similar results to grafted primary photoreceptors.
Integrated photoreceptors, whether grafted into wild-type
or photoreceptor degeneration mouse models, acquired a
mature morphology, and expressed phototransduction and
synaptic markers. However, two studies showed that integration
rates of mouse ESC-derived photoreceptors were significantly
lower when compared to transplanted primary photoreceptors
(Gonzalez-Cordero et al., 2013; Decembrini et al., 2014).
Currently, studies assessing functional recovery after
transplantation of retinal organoid-derived photoreceptors are
severely limited as the cited studies mainly analyzed survival,
differentiation, and maturation of donor photoreceptors.
Particularly, transplantation studies using photoreceptors
isolated from human PSC-derived organoids have not been
published yet. However, with the generation of photoreceptor-
specific human reporter ESC lines (Kaewkhaw et al., 2015),
implementation of protocols for the generation of retinal
organoids from hiPSCs (Zhong et al., 2014)/hESCs (Shirai et al.,
2016), and given the high number of laboratories currently
working on this topic several publications are awaited within
the near future. Importantly, the extended time lines for the
generation of cone (∼60–80 days) or rod (∼120–200 days)
photoreceptors besides high variability in the differentiation
process significantly extends the analysis and experimental set
up in comparison to the mouse system.
PARADIGM SHIFT IN PHOTORECEPTOR
REPLACEMENT THERAPY
The common notion that donor photoreceptors migrate and
structurally integrate into the recipient photoreceptor layer was
recently challenged (Pearson et al., 2016; Santos-Ferreira et al.,
2016a; Singh et al., 2016). The three studies provide strong
evidence, that the majority of donor photoreceptors instead
remain in the sub-retinal space and exchange cytoplasmic
material (including fluorescent reporter proteins) with
endogenous host photoreceptors rather than structurally
integrating into the recipient retina. This results in the labeling
of host photoreceptors and consequently misinterpretation of
labeled cells as structurally integrated donor cells (Figure 5).
This material exchange is limited to components of the
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FIGURE 5 | Paradigm shift in photoreceptor replacement therapy. Following subretinal transplantation, structural integration of donor photoreceptors was
assumed as the main mechanism for vision improvement in previous pre-clinical studies. Instead, the majority of “integrated” donor cells in the ONL of the host retina
represent host photoreceptors which exchanged cytoplasmic material with donor photoreceptors located in the subretinal space. Cell-cell connections, free molecule
diffusion or vesicular transport are assumed as possible mechanisms. SRS, subretinal space; RPE, retinal pigment epithelium; OS/IS, outer segment/inner segment;
ONL, outer nuclear layer.
cytoplasm without translocation of the nucleus. Thus, a
complete fusion, as it was seen between transplanted bone
marrow derived progenitor cells and diverse cell-types in
several tissues (Kemp et al., 2012; Yamashita et al., 2012)
which resulted in the formation of bi-nucleated perikaryons,
can be ruled out for the observed phenomenon in the retina.
Instead, other cell-cell interactions like tunneling nanotubes
or vesicular transport are hypothesized as potential transfer
mechanisms.
The observed material transfer between donor and host
photoreceptors has important implications for cell-based
treatment approaches in retinal degeneration as it demands a
reinterpretation of the above discussed former studies. Several
topics have to be reconsidered including the general migratory
and synaptogenic potential of donor photoreceptors. Therefore,
proper animal models with severe retinal degeneration,
i.e., complete photoreceptor loss, in which no material
exchange between donor and host cells has been observed,
should be used as benchmark models for photoreceptor
replacement studies (Singh et al., 2013; Santos-Ferreira et al.,
2016a).
On the other hand, the transfer of biomaterial might
represent an unexpected novel way for the development of cell-
based therapeutic interventions in retinopathies. Though it still
remains to be shown to what extent aberrant photoreceptors
also exchange cellular content with donor cells. The observed
functional improvements in mouse models of rod (Pearson et al.,
2012; Barber et al., 2013) and cone (Santos-Ferreira et al., 2015)
degeneration after photoreceptor transplantation might point
toward a cell support therapy, in which donor cells transfer
“healthy” components to diseased host photoreceptors allowing
functional repair.
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CONCLUDING REMARKS
Significant progress has been achieved within the last
decade in the evaluation and development of photoreceptor
transplantation strategies aiming to treat retinal degenerative
diseases. Besides the surgical accessibility of the retina, its
separation from the rest of the body and partially immune
privileged environment, donor photoreceptors have to generate
only short processes to contact second order neurons; thus the
retina might serve as a blueprint for cell replacement approaches
in the central nervous system.
Young post-mitotic photoreceptor precursors rather than
proliferating retinal progenitor cells were identified as the most
successful cell-type for photoreceptor grafting as they showed
long term survival and maturation following transplantation
into the adult degenerated mouse retina (MacLaren et al., 2006;
Bartsch et al., 2008) culminating in functional improvements by
rod transplantation in mouse models of RP (Pearson et al., 2012)
and daylight vision repair by donor cone-like photoreceptors
grafted into a cone degeneration model (Santos-Ferreira et al.,
2015). Additionally, technologies for the enrichment of rod
photoreceptors based on photoreceptor-specific fluorescent
donor lines (MacLaren et al., 2006) besides cell surface markers
using flow cytometry (Lakowski et al., 2011) or MACS (Eberle
et al., 2011) allowed significant improvements in transplantation
outcomes.
Importantly, the observed functional improvements by
photoreceptor transplantation in mouse models of retinal
degeneration that still contain significant amounts of endogenous
photoreceptors might be achieved by the transfer of cytoplasmic
material from donor to host photoreceptors rather than
structural migration and integration of grafted cells (Pearson
et al., 2016; Santos-Ferreira et al., 2016a). These findings demand
a reconsideration of cell-based strategies for treating retinal
degenerative diseases characterized by dysfunctional but still
existing photoreceptors that might benefit from therapeutic
support by donor cells (cell support therapy). Conversely, retinal
degeneration characterized by complete loss of photoreceptors
has to be considered as the main target for photoreceptor
replacement approaches (cell replacement therapy).
Another essential step toward the development of cell-
based therapies in the retina represents the ground-breaking
technology of PSC-derived retinal organoids and their use
for the generation of high amounts of transplantation-
competent photoreceptors (Eiraku et al., 2011; Nakano et al.,
2012; Gonzalez-Cordero et al., 2013; Decembrini et al., 2014;
Santos-Ferreira et al., 2016b; Völkner et al., 2016). However,
given the high variability still observed in the differentiation
outcome of human PSCs further detailed knowledge of retina
and photoreceptor development for targeted modification of
molecular pathways will be essential for developing pipelines
that allow clinical grade photoreceptor transplant production
according to good manufacturing practice (GMP) guidelines
(Wiley et al., 2016). Furthermore, the extended time periods
for the generation of human photoreceptors, particularly rods,
with more than 100 days in vitro, represents a major technical
challenge for robust clinical grade cell production.
As retina organoids show significant heterogeneity the
enrichment of target cells by GMP adaptable techniques will be
essential for future clinical use.MACSmight represent a potential
method for such purification as it has been established for cell
sorting approaches in clinical applications, e.g., hematopoietic
cell-therapies. However, although potential cell surface markers
for cell sorting have been identified for rods (Eberle et al., 2011;
Lakowski et al., 2011; Kaewkhaw et al., 2015), specific markers or
marker-panels for human cones still need to be established.
The observation of cell material transfer between donor and
host photoreceptors has particular implications on our view of
connectivity and synapse formation between donor cells and
second order neurons, as most of the previously described
connections might actually represent still existing synapses
between endogenous photoreceptors and their target cells rather
than newly formed interactions. Therefore, detailed studies have
to assess the connections of donor photoreceptors to endogenous
bipolars and horizontals. Particularly when considering the
significant remodeling and dendritic arborization in late stage
retinal degeneration, where most, if not all, photoreceptors have
been lost, the generation of new specific and proper synaptic
connections might represent one of the major challenges in the
field.
Finally, in the long run one of the major disease conditions to
be targeted by retinal cell transplantation is late stage dry AMD
with its deleterious loss of both, cone photoreceptors and RPE,
that might demand co-injection strategies. With PSC-derived
RPE transplantation already performed in first trials (Schwartz
et al., 2015), a blueprint to bring stem cell-based cell products to
the clinic has been introduced, which will be of enormous help
for also introducing photoreceptor transplantation to patients.
However, animal models that can serve as appropriate models
for late stage dry AMD are missing and their development would
be of tremendous help to pre-clinically study cone and RPE
replacement approaches. Hence, photoreceptor transplantation
represents a highly dynamic research field that considerably
progressed within the last decade, but with a number of potential
road blocks still remaining to be tackled on the path to clinical
application.
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